TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 305 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q3 2023. The put-call ratio across all filers is 0.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $78,157 | -70.2% | 4,975 | -68.8% | 0.00% | -100.0% |
| Q1 2023 | $262,658 | +10.4% | 15,938 | -13.3% | 0.00% | – |
| Q3 2022 | $238,000 | -68.4% | 18,386 | -65.8% | 0.00% | -100.0% |
| Q2 2022 | $754,000 | +135.6% | 53,732 | +140.6% | 0.00% | – |
| Q1 2022 | $320,000 | -55.2% | 22,329 | -43.1% | 0.00% | -100.0% |
| Q4 2020 | $714,000 | +82.6% | 39,227 | +104.3% | 0.00% | -75.0% |
| Q1 2019 | $391,000 | – | 19,202 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bartlett & Co. LLC | 20,781 | $296 | 0.01% |
| Valued Wealth Advisors LLC | 231 | $3,574 | 0.00% |
| BALDWIN BROTHERS LLC/MA | 2,035 | $29,039 | 0.00% |